期刊文献+

LOX-1在2型糖尿病大鼠肾小管间质中的表达及其意义 被引量:7

Expression of LOX-1 in type 2 diabetic rat tubular interstitial tissues
下载PDF
导出
摘要 目的:探讨血凝素样氧化低密度脂蛋白受体1(LOX-1)在糖尿病肾病(DN)中的作用及其机制。方法:SD大鼠随机分为正常对照组和糖尿病模型组。以高脂高糖饮食加低剂量注射链脲佐菌素复制2型糖尿病大鼠模型。动态观察:生化指标和24 h尿白蛋白排泄率(UAER);苏木素伊红(HE)和过碘酸-雪夫反应(PAS)染色观察肾脏病理,免疫组化检测LOX-1和转化生长因子β1(TGF-β1)蛋白表达,荧光定量聚合酶链反应检测LOX-1和TGF-β1mRNA表达,ELISA检测血清单核细胞趋化因子-1(MCP-1)、细胞间黏附分子(ICAM)和肿瘤坏死因子α(TNF-α)的浓度。结果:随着造模时间的延长,血清中总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白(LDL)含量和UAER逐渐升高,高密度脂蛋白(HDL)在成模时升高,但随着病变进展含量减少;LOX-1和TGF-β1在肾小管中蛋白表达增加;与正常组比较,模型各组LOX-1和TGF-β1蛋白和mRNA表达逐渐增加;与正常组比较,模型各组血清MCP-1、ICAM和TNF-α水平均增高;LOX-1 mRNA表达与UAER、TNF-α和TGF-β1mRNA表达量之间呈正相关(r值分别为0.509、0.649和0.800)(P<0.05)。结论:LOX-1在2型糖尿病肾小管中表达增加,使肾小管损伤,其作用可能通过炎症因子释放和炎症细胞浸润而实现,提示其在DN发生和发展过程中起重要作用。 AIM: To explore the effect of lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1) on type 2 diabetic nephropathy in rats. METHODS: The Sprague-Dawley (SD) rats were randomly divided into control group and model group. The animal model was established by intraperitflneal injection of low-dose streptozotocin ( STZ, 30 mg/ kg) plus feeding with high-fat/high-glucose diets for one month. Biochemical parameters and 24 h urine album excretion rate (UAER) were monitored. The morphological changes of the renal tissue were examined under microscope with hema- toxylin-eosin (HE) and periodic acid-Schiff reaction (PAS) staining. The protein levels of LOX-1 and transforming growth factor β1 (TGF-β1) in the renal tissues were determined by the method of immunohistochemistry. The mRNA expression of LOX-1 and TGF-β1 was detected by real-time polymerase chain reaction. The serum levels of monocyte chemotactic protein- 1 (MCP-1), intercellular adhesion molecule (ICAM) and tumor necrosis factor α (TNF-α were measured by enzyme- linked immunosorbent assay (ELISA). The correlation between LOX-1 and UAER, inflammatory factors and TGF-β1 was analyzed. RESULTS: Compared with normal group, total cholesterol (TC), triglyceride (TG), low-density lipoprotein (LDL) and UAER in model groups markedly increased, high-density lipoprotein (HDL) only increased at 0 week, then decreased at 4 and 8 weeks. The expression of LOX-1 and TGF-β1 at mRNA and protein levels was increased, as well as the concentration of serum inflammatory factors such as MCP-1, ICAM and TNF-α. The obvious relations between LOX-1 mRNA with UAER, TNF-α and TGF-β1 were observed (r =0. 509, 0. 649 and 0. 800, respectively, P 〈0.05). CON- CLUSION: LOX-1 is significantly increased in type 2 diabetic rat tubular interstitial tissues and aggravates the dysfunction of renal tubules by releasing inflammatory factors and promoting inflammatory cell infiltration.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2013年第1期50-55,共6页 Chinese Journal of Pathophysiology
基金 浙江省教育厅项目(No.200907543)
关键词 糖尿病肾病 血凝素样氧化低密度脂蛋白受体1 肾小管-肾间质损伤 炎症 Diabetic nephropathies Lectin-like oxidized low-density lipoprotein receptor 1 Tubular-intersti- tial injury Inflammation
  • 相关文献

参考文献3

二级参考文献154

  • 1徐梓辉,周世文,钱桂生,王艳梅,汤建林,黄永平,陈维中,徐颖,应懿.2型糖尿病合并动脉粥样硬化大鼠模型的建立[J].中国病理生理杂志,2006,22(1):205-208. 被引量:8
  • 2Mark EM, Ralph AD, Marion JF, et al. Nephropathy in diabetes[J]. Diabetes Care, 2004, 27 (Supplement 1): S79 - S83.
  • 3Vaziri ND. Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences [ J ]. Am J Physiol Renal Physiol, 2006, 290 (2) : 262 - 272.
  • 4Li JS, Nabil I-I, Wei PZ, et al. Role of sterol regulatory element - binding protein 1 in regulation of renal lipid metabolism and glomerulosclerosis in diabetes mellitus [ J]. J Biol Chem, 2002, 277(21): 18919-18927.
  • 5Greg HT, Terri JA. Rodent models of streptozotocin - induced diabetic nephropathy [ J]. Nephrology, 2007, 12 (3) : 261 - 266.
  • 6Stefan B, Varman S, Katsutaro M, et al. Activation of the farnesoid X receptor improves lipid metabolism in combined hyperlipidemic hamsters[J]. Am J Physiol Endocrinol Metab,2006, 290(4) : E716 - E722.
  • 7Mikio S, Hideyuki Y, Tsutomu H, et al. High -fat diet in low - dose - streptozotocin - treated heminephrectomized rats induces all features of human type 2 diabetic nephropathy: A new rat model of diabetic nephropathy [J]. Nutr Metab Cardiovasc Dis, 2006, 16(7) : 477 - 484.
  • 8Itabe H, Takano T. Oxidized low density lipoprotein: the occurrence and metabolism in circulation and in foam cells[J]. J Atheroscler Thromb, 2000, 7(3): 123 - 131.
  • 9Sawanura T, Kume N, Aoyama T, et al. An endothelial receptor for oxidized low- density lipoprotein [ J]. Nature,1997, 386(6): 73 - 77.
  • 10Kataoka H, Kume N, Miyamoto S, et al. Expression of lectinlike oxidized low- density lipoprotein receptor- 1 in human atherosclerosis[J]. Circulation, 1999, 99(24): 3110-3117.

共引文献64

同被引文献48

引证文献7

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部